ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.28
-0.06 (-0.64%)
At close: Feb 27, 2026, 4:00 PM EST
9.29
+0.01 (0.11%)
After-hours: Feb 27, 2026, 5:17 PM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $917.32 million as of February 27, 2026. Its market cap has decreased by -18.84% in one year.
Market Cap
917.32M
Enterprise Value
798.91M
1-Year Change
-18.84%
Ranking
Category
Stock Price
$9.28
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $917.32M, an increase of 61.43%. That is a compound annual growth rate of 15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 917.32M | -20.34% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 973.62M |
| Valneva SE | 971.11M |
| ArriVent BioPharma | 948.23M |
| Xencor | 936.53M |
| SpyGlass Pharma | 932.89M |
| Theravance Biopharma | 924.77M |
| GH Research | 921.14M |
| Cullinan Therapeutics | 915.68M |